Uramustine

  • CAT Number: I004511
  • CAS Number: 66-75-1
  • Molecular Formula: C8H11Cl2N3O2
  • Molecular Weight: 252.1
  • Purity: ≥95%
Inquiry Now

<p style=/line-height:25px/>Uramustine is an antineoplastic agent with of 5.1μM in K562 human leukemia cell line.<br>IC50 value: 5.1 μM<br>Target: DNA alkylator/crosslinker<br>Uramustine is a chemotherapy drug which belongs to the class of alkylating agents. It is used in lymphatic malignancies such as non-Hodgkin/’s lymphoma. It works by damaging DNA, primarily in cancer cells that preferentially take up the uracil due to their need to make nucleic acids during their rapid cycles of cell division. The DNA damage leads to apoptosis of the affected cells.</p>

Catalog Number I004511
CAS Number 66-75-1
Molecular Formula

C8H11Cl2N3O2

Purity 95%
Target DNA alkylator/crosslinker
Solubility DMSO: ≥ 29 mg/mL
Storage Store at -20C
IC50 5.1 μM
Reference

1:J Med Chem. 2002 Aug 15;45(17):3630-8. Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A.Baraldi PG,Romagnoli R,Guadix AE,Pineda de las Infantas MJ,Gallo MA,Espinosa A,Martinez A,Bingham JP,Hartley JA, PMID: 12166936 </br><span>Abstract:</span> The design, synthesis, characterization, DNA binding properties, and cytotoxic activity of a novel series of hybrids, namely, a molecular combination of the natural antibiotic distamycin A and the antineoplastic agent uramustine, are reported, and the structure-activity relationships are discussed. This homologous series 29-34 consisted of the minor groove binder distamycin A joined to uramustine (uracil mustard) by suitable aliphatic carboxylic acid moieties containing a flexible polymethylene chain that is variable in length [(CH(2))(n)(), where n = 1-6). All the hybrid compounds in this series exhibit enhanced activity compared to both distamycin A and uramustine derivatives 22-27 used for conjugation, giving IC(50) values in the range 7.26-0.07 microM following a 1 h exposure of human leukemic K562 cells, with maximal activity shown when n = 6. The distance between the uramustine and distamycin frame is crucial for the cytotoxicity, with compounds having linker lengths of four to six being at least 20-fold more cytotoxic than linker lengths one to three. Taq polymerase stop experiments demonstrated selective covalent binding of uramustine-distamycin hybrids to A/T rich DNA sequences, which was again more efficient with compounds 32-34 with a longer linker length. Two consequences can be derived from our study: (a) the distamycin moiety directs binding to the minor groove of A/T rich DNA sequences and, consequently, is responsible for the alkylation regioselectivity found in footprinting studies; (b) the higher flexibility due to a longer linker between the distamycin and uracil moieties allows the formation of complexes with the mustard moiety situated more deeply in the minor groove and, hence, with better alkylating properties.

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!